Effect of Rifampin‐Mediated OATP1B1 and OATP1B3 Transporter Inhibition on the Pharmacokinetics of the P2Y12 Receptor Antagonist Selatogrel

por Schilling, Uta, Dingemanse, Jasper, Voors‐Pette, Christine, Romeijn, Christel, Dogterom, Peter, Ufer, Mike
Publicado 2020

Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the P2Y12 receptor antagonist selatogrel

por Schilling, Uta, Hsin, Chih‐Hsuan, Delahaye, Stephane, Krause, Andreas, Wuelfrath, Hauke, Halabi, Atef, Dingemanse, Jasper
Publicado 2022